Globeflex Capital L P Purchases New Stake in Addus HomeCare Corporation $ADUS

Globeflex Capital L P bought a new position in shares of Addus HomeCare Corporation (NASDAQ:ADUS - Free Report) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 16,275 shares of the company's stock, valued at approximately $1,635,000. Globeflex Capital L P owned 0.09% of Addus HomeCare as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors also recently modified their holdings of the business. Leeward Investments LLC MA lifted its position in Addus HomeCare by 9.4% in the 1st quarter. Leeward Investments LLC MA now owns 120,857 shares of the company's stock valued at $11,318,000 after purchasing an additional 10,414 shares during the last quarter. Bank of America Corp DE grew its position in Addus HomeCare by 11.3% in the 1st quarter. Bank of America Corp DE now owns 323,037 shares of the company's stock worth $30,252,000 after purchasing an additional 32,714 shares during the last quarter. Summit Creek Advisors LLC bought a new position in Addus HomeCare in the 2nd quarter worth about $8,552,000. Vanguard Group Inc. increased its stake in shares of Addus HomeCare by 0.8% in the fourth quarter. Vanguard Group Inc. now owns 1,308,605 shares of the company's stock valued at $140,531,000 after purchasing an additional 10,501 shares during the period. Finally, TimesSquare Capital Management LLC acquired a new stake in shares of Addus HomeCare in the second quarter valued at approximately $31,502,000. 95.35% of the stock is currently owned by institutional investors.

Insider Activity at Addus HomeCare

In related news, insider Heather Brianne Dixon sold 288 shares of the stock in a transaction on Monday, June 22nd. The stock was sold at an average price of $93.77, for a total value of $27,005.76. Following the completion of the transaction, the insider owned 44,371 shares in the company, valued at $4,160,668.67. This trade represents a 0.64% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 4.10% of the stock is currently owned by corporate insiders.

Addus HomeCare Price Performance

NASDAQ ADUS opened at $120.82 on Tuesday. Addus HomeCare Corporation has a 1 year low of $87.95 and a 1 year high of $124.43. The business's fifty day moving average is $109.99 and its two-hundred day moving average is $102.58. The stock has a market capitalization of $2.26 billion, a P/E ratio of 21.20, a P/E/G ratio of 1.62 and a beta of 0.87. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.69 and a current ratio of 1.69.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last released its quarterly earnings data on Monday, August 3rd. The company reported $1.73 earnings per share for the quarter, topping the consensus estimate of $1.70 by $0.03. The business had revenue of $377.41 million during the quarter, compared to analyst estimates of $376.24 million. Addus HomeCare had a return on equity of 9.96% and a net margin of 7.13%.The company's revenue was up 8.0% compared to the same quarter last year. During the same period last year, the company posted $1.49 EPS. On average, research analysts forecast that Addus HomeCare Corporation will post 6.29 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

ADUS has been the subject of a number of analyst reports. Citigroup reiterated a "market outperform" rating on shares of Addus HomeCare in a research report on Friday, July 24th. Royal Bank Of Canada lifted their price objective on shares of Addus HomeCare from $130.00 to $134.00 and gave the company an "outperform" rating in a research note on Wednesday, August 5th. Citizens Jmp reaffirmed a "market outperform" rating and issued a $142.00 price objective on shares of Addus HomeCare in a report on Monday, May 18th. Barclays increased their target price on shares of Addus HomeCare from $92.00 to $96.00 and gave the company an "underweight" rating in a research report on Wednesday, July 8th. Finally, Weiss Ratings raised shares of Addus HomeCare from a "hold (c-)" rating to a "hold (c)" rating in a research note on Thursday, July 9th. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $130.88.

Addus HomeCare Profile

Addus HomeCare NASDAQ: ADUS is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients' independence and quality of life.

The company's core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source